Effect of HM30181 mesylate salt-loaded microcapsules on the oral absorption of paclitaxel as a novel P-glycoprotein inhibitor-Reference-Cited by-同舟云学术

Effect of HM30181 mesylate salt-loaded microcapsules on the oral absorption of paclitaxel as a novel P-glycoprotein inhibitor

Published:2016-06 Issue:1-2 Volume:506 Page:93-101
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Kim Jin Cheul,Kim Kyeong Soo,Kim Dong Shik,Jin Sung Giu,Kim Dong Wuk,Kim Yong Il,Park Jae-Hyun,Kim Jong Oh,Yong Chul Soon,Youn Yu Seok,Woo Jong Soo,Choi Han-Gon

Funder

National Research Foundation of Korea

Korea government

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference53 articles.

1. Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel;Akiyama;Am. J. Pathol.,2015

2. A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer;Ahn;Cancer Chemother. Pharmacol.,2014

3. Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice;Bardelmeijer;Invest. New Drugs,2004

4. Interaction of HM30181A with P-glycoprotein at the murine blood–brain barrier assessed with positron emission tomography;Bauer;Eur. J. Pharmacol.,2012

5. Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel;Britten;Clin. Cancer Res.,2000

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-release of paclitaxel and encequidar from amorphous solid dispersions increase oral paclitaxel bioavailability in rats;International Journal of Pharmaceutics;2024-04

2. Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers;European Journal of Medicinal Chemistry;2023-11

3. Oral paclitaxel and encequidar in patients with breast cancer: a pharmacokinetic, safety, and antitumor activity study;Therapeutic Advances in Medical Oncology;2023-01

4. The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers;Current Topics in Medicinal Chemistry;2022-12

5. Resveratrol‐β‐Lactoglobulin Composite Nanocoating by Layer‐by‐Layer Assembly with Fe(III)‐Tannic Acid Complex;Chemistry – An Asian Journal;2021-10-11